Philip Tsai

IMNM

Philip Tsai serves as Chief Technical Officer at Immunome, Inc. (IMNM). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$506.5K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$506.5K

Companies Traded

IMNM

Active Period

Nov 2024 – Dec 2025

3 total trades

Most Recent

Buy IMNM

Dec 19, 2025 · $204.9K

Philip Tsai's Insider Trading at Immunome, Inc. (IMNM)

Buys

3 · $506.5K

Sells

0 · $0.00

Total Shares Bought

43,300

Total Shares Sold

IMNM Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 19, 2025	Buy	10,000	$20.49	$204.9K	0
Mar 24, 2025	Buy	12,300	$8.42	$103.6K	0
Nov 25, 2024	Buy	21,000	$9.43	$198.0K	21,000

Related Insiders

Jack Higgins

officer: Chief Scientific Officer

IMNMSell · Apr 3, 2026

Max Rosett

officer: Chief Financial Officer

IMNMSell · Apr 3, 2026

SIEGALL CLAY B

President and CEO

IMNMBuy · Mar 31, 2026

WAGENHEIM PHILIP

director

IMNMSell · Mar 23, 2026

BIENAIME JEAN JACQUES

Director

IMNMBuy · Mar 12, 2026

Isaac Barchas

Director

IMNMSell · Dec 22, 2025

Explore More Insider Trading Data

IMNM Insider Trading Activity

View all insider trades at Immunome, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity